Organon OGN Asia Pacific and Japan — Revenue
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Organon in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Organon’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Organon's asia pacific and japan — revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Organon's asia pacific and japan — revenue?
- Organon (OGN) reported asia pacific and japan — revenue of $226M in Q1 2026.
- How has Organon's asia pacific and japan — revenue changed year-over-year?
- Organon's asia pacific and japan — revenue decreased by 10.0% year-over-year, from $251M to $226M.
- What is the long-term trend for Organon's asia pacific and japan — revenue?
- Over 4 years (2021 to 2025), Organon's asia pacific and japan — revenue has grown at a -3.9% compound annual growth rate (CAGR), from $1.17B to $1B.
- What does asia pacific and japan — revenue mean?
- This metric represents the total net sales generated from pharmaceutical products and health solutions within the Asia Pacific and Japan geographic region. It reflects the company's market penetration, demand for its portfolio of women's health, biosimilars, and established brands, and the overall commercial performance in these specific international markets. Monitoring this revenue stream helps investors assess the company's geographic diversification and the success of its regional commercial strategies.